Field of the Invention
The present disclosure is generally directed to methods for making a medical article (for example, catheters, cannulas, and sheaths) for the introduction and/or delivery into a body space, such as, for example, an artery, vein, vessel, body cavity, or drainage site. The disclosure is also directed to such medical articles and to access devices that place such medical articles into an artery, vein, vessel, body cavity, or drainage site.
Description of the Related Art
Various medical articles, for example, catheters, cannulas, sheaths, etc., are often introduced into a patient, for example, in an artery, vein, body cavity, or drainage site, to deliver fluids to, or withdraw fluids from, the patient. For example, a catheter or vascular sheath can be introduced into a patient's blood vessel using the Seldinger or a modified Seldinger technique. These techniques involve inserting an access needle into the patient's blood vessel and then inserting a guidewire through the needle and into the vessel. The needle is removed, and a dilator and sheath, either separately, or in combination, are inserted over the guidewire, through tissue, and into the vessel. The dilator and guidewire are then removed and discarded. The sheath can be left in the vessel, for example, to deliver medical fluids to the patient, or a catheter or other medical article can be inserted through the sheath into the vessel to a desired location.
A medical provider may need to bend and manipulate the sheath and/or catheter during insertion and/or after insertion during use. Although some existing sheaths and catheters have some flexibility to allow for such manipulation, existing devices may kink when bent to a certain radius of curvature, for example, a 90 degree bend. When medical articles kink, they can disrupt the flow of fluids within the device and hinder performance of the device. Additionally, some sheaths and catheters are more prone to re-kink or re-crease after initially kinking and may subsequently kink at an earlier point, for example, at a smaller angle of bending.
In view of the foregoing, there is a need for an improved medical article and method of making such a medical article with improved flexibility, memory, kink-resistance, and/or resilience.
In some embodiments, a method for forming a flexible medical article includes extruding a polymer, for example, a polycarbonate-urethane copolymer or another form of urethane. The method can further include heat treating the flexible medical article by annealing under conditions of, for example, 248° F. for one hour. In some embodiments, the polymer is selected have the property of reduced rigidity (i.e., increased flexibility) when exposed to heat. The method can further include cutting the medical article into desired lengths before and/or after annealing. Optionally, the method can also include flaring one end of the medical article to be coupled to a hub and over-molding the flared end onto the hub and/or forming one end of the medical article into a tip.
In some embodiments, a method for forming a flexible medical article includes extruding a polymer, for example, a polycarbonate-urethane copolymer or another form of urethane, to form a tubular shaft with at least one lumen. The method can further include heat treating the tubular shaft by annealing under conditions of, for example, 248° F. for one hour. In some embodiments, the polymer is selected have the property of reduced rigidity (i.e., increased flexibility) when exposed to heat. The method can further include cutting the tubular shaft into desired lengths before and/or after annealing. The method can also include flaring one end of the tubular shaft to be coupled to a hub and over-molding the flared end onto the hub and/or forming one end of the tube into a tip. In one embodiment, the tubular shaft is annealed sufficiently so as to be capable of bending up to about 120° without kinking. In another embodiment, the polymer is capable of withstanding pressures up to 300 psi and flow rates of up to 130 ml/min.
In some embodiments, a flexible medical article or tube which can be used as, for example, a sheath or catheter to be introduced into a body lumen of a patient is formed by extruding a polymer to form a tube and annealing the tube.
In one embodiment, the flexible medical article additionally comprises a needle having a needle shaft and a needle hub, a dilator having a dilator shaft and a dilator hub, and a guidewire, wherein the dilator shaft is coaxially disposed on the needle shaft with the needle hub and dilator hub juxtaposed, the guidewire is at least partially disposed in the needle, and the shaft is coaxially disposed on the dilator shaft with the hub juxtaposed the dilator hub.
In one embodiment, a method of using a medical article having a flexible shaft comprising annealed urethane polycarbonate comprises inserting the shaft into a vessel over a guidewire, withdrawing the guidewire, and bending the shaft to lie substantially parallel to the skin, and retaining the shaft in the bent position without kinking the shaft.
The foregoing and other features, aspects, and advantages of the method of making a medical article and corresponding medical article are described in detail below with reference to the drawings of various embodiments, which are intended to illustrate and not to limit the embodiments of the invention. The drawings comprise the following figures of one embodiment, in which:
Embodiments of the invention will now be described with reference to the accompanying figures, wherein like numerals refer to like elements throughout the following description and drawings. Although several embodiments, examples and illustrations are disclosed below, it will be understood by those of ordinary skill in the art that the invention described herein extends beyond the specifically disclosed embodiments, examples and illustrations and can include other uses of the invention and obvious modifications and equivalents thereof. The terminology used in the description presented herein is not intended to be interpreted in any limited or restrictive manner simply because it is being used in conjunction with a detailed description of certain specific embodiments of the invention. In addition, embodiments of the invention can comprise several novel features and no single feature is solely responsible for its desirable attributes or is essential to practicing the inventions herein described.
The present disclosure provides a medical article (e.g., a catheter, cannula, or sheath) that can be delivered into a space, such as a blood vessel or drainage site, by an access device.
In various circumstances a medical provider may wish to introduce a catheter and/or sheath into a space within a patient's body, for example, a blood vessel or drainage site, to introduce fluids to the space or remove fluids from the space. Various access devices are known in the art. Examples of an improved access device are described in PCT Application No. PCT/US2012/039740, entitled “ACCESS DEVICE,” filed May 25, 2012, which is incorporated by reference in its entirety herein.
The present embodiment of the access device is disclosed in the context of placing an exemplary single-piece, medical article into a body space within a patient. Once placed, the medical article can then be used to receive other medical articles (e.g., guidewires) to provide access into the body space and/or be used to provide a passage way for introducing fluids into the body space or removing (e.g., draining) fluids from the body space. In the illustrated embodiment in
For example, but without limitation, the access device disclosed herein can also be configured to directly or indirectly place central venous catheters, peripherally inserted central catheters, hemodialysis catheters, surgical drainage tubes, tear-away sheaths, multi-piece sheaths, PICC lines, IV lines, scopes, as well as electrical conduit for wires or cables connected to external or implanted electronic devices or sensors. As explained above, the medical articles listed above may be directly placed in the patient via the dilator, needle, and guidewire of the access device or subsequently placed within the patient via a medical article that was placed within the patient via the dilator, needle, and guidewire of the access device.
Further, the embodiments disclosed herein are not limited to co-axial insertion of a single medical article. For example, two catheters may be inserted in the patient via an inserted sheath or a second catheter may be inserted in the patient via an inserted first catheter. Further, in addition to providing a conduit into the vessel or other body space, the medical article inserted via the dilator, needle, and guidewire can form a lumen that is in addition to the lumen(s) of the subsequently inserted medical article. One skilled in the art can also find additional applications for the devices and systems disclosed herein. Thus, the illustration and description of the access device in connection with a sheath (e.g., for micro puncture applications) is merely exemplary of one possible application of the access device.
Each of these components can include a luminal fitting at a terminal end or transition (e.g., a hub) and elongated structure that extends from the fitting. Thus, in the illustrated embodiment, the needle 22 includes a needle body 32 that extends distally from the needle hub 34, the dilator 24 includes a dilator shaft 36 that extends distally from a dilator hub 38, and the sheath 26 includes a sheath body 40 that extends distally from a sheath hub 42. The guidewire section 28 can include a guidewire 44 and preferably a guidewire hub or cap 46. In the illustrated embodiment, the guidewire hub 46 is disposed on the proximal end of the guidewire 44; however, in other applications, the hub 46 can be disposed at a location between the ends of the guidewire 44.
The needle body 32 can have a sufficiently long length to access a targeted subcutaneous body space and can have a sufficient gauge size to withstand the insertion forces when accessing the body space without causing undue trauma. For many applications, the needle body can have a length between 3-20 cm, and more preferably between 3-10 cm. For example, to access a body space (e.g., a vessel) in the thorax of an adult human, the needle body 32 preferably has a length of 7 cm or greater, and more preferably has a length of 9 cm or greater, and most preferably has a length of 9 to 10 cm. The size of the needle preferably is 18 gauge or smaller, and more preferably between 18-28 gauge, and most preferably between 18-26 gauge for micro-puncture applications (e.g., peripheral IVs). For applications with a neonate, the length and gauge of the needle body 32 should be significantly shorter and smaller, for example preferably between 3-4 cm and between 26-28 gauge.
As explained below in greater detail, the guidewire 44 can be introduced through a hollow and preferably tapered portion of the needle hub 34, through the needle body 32, and into a punctured vessel. Advantageously, the tapered portion can guide the guidewire 44 toward the bore of the needle 22. Further, in some embodiments this tapered portion can provide a female luer connection. The guidewire 44 allows the healthcare provider to guide the dilator 24 and sheath 26 into the vessel.
In some embodiments, the sheath 26 can have relief elements 140, best illustrated in
The relief element 140 can include a variety of shapes and structures to provide additional support to sheath body 40 while still providing some flexibility thereto. For example, the relief element 140 can include a substantially hollow elongated member, an approximately rectangular or cylindrical tubular shape, and can be configured with a wall thickness and material that provide some support and flexibility. The relief element 140 can be configured with a substantially continuous or unbroken surface, or can include gaps, apertures, recessions, or other structure extending partially or completely through its surface to provide additional flexibility against kinking. The relief element 140 can include various support structures such as circumferential or longitudinal (axial) ribs, struts, and the like.
In other embodiments, the relief element is absent. Improved patency of the bent medical article (e.g., the sheath) is obtained by the annealing process described below. In such embodiments, a short outer sleeve can extend from the sheath hub to the sheath shaft to form a relatively smooth transition region.
The sheath body 40 can be a single piece sheath through which fluid (e.g., an IV solution or imaging solution) is introduced into the vessel or withdrawn from the vessel. In one form, the sheath body 40 is an extended dwell (e.g., up to 29 days) peripheral catheter of 4 or 5 French having a single lumen with a length of about 80 mm. The sheath body 40 alternatively can be a single or multi-piece body through which other medical devices are introduced into the vessel. For example, a catheter or other medical article (e.g., a guidewire) can be inserted into the vessel through the sheath body. In such an embodiment, the sheath body 40 forms a conduit for insertion of the catheter or other medical article (e.g., a guidewire). In some embodiments, the sheath body 40 can be split along its length to ease removal of the sheath once the catheter or other medical article (e.g., PICC) has been placed in the patient. In some embodiment, the sheath or a portion of the sheath can, in addition to providing a conduit, form a lumen that is in addition to the lumen(s) of the catheter. For example, an equivalent to a triple lumen catheter can be formed by inserting a dual lumen catheter through the sheath body 40 with the sheath body 40 itself forming a third lumen.
During or after the insertion of sheath 26 into a patient, prior forms of the sheath body 40 could over-flex, kink, and/or permanently deform, which would reduce or inhibit its functionality. Prior sheath body 40 would thus be susceptible to such kinking or permanent deformation, for example, at the interface between sheath body 40 and the sheath hub 42, or at portions upstream or downstream of the interface between sheath body 40 and the sheath hub 42. A kink or permanent deformation would inhibit the flow of fluid, such as blood or medicine, through sheath body 40. Additionally, if access device 20 were used, for example, for IV lines, PICC lines, and other higher pressure applications, the proximal end of sheath body 40 could move erratically in a “whipping” motion as the pressurized fluid flows through sheath 26. To reduce the likelihood of such kinking or permanent deformation within sheath body 40, and/or to reduce the likelihood of such whipping during the deployment of access device 20, in some embodiments, sheath 26 can include various materials and an optional relief element 140, as described above, that can provide support to sheath 26.
In some embodiments, the sheath can be made of a material with sufficient flexibility to facilitate the insertion of the sheath into a patient and fluid transfers through the sheath. In some embodiments, the sheath can be made of a material that varies in flexibility depending on the environment to which it is exposed. For example, the sheath can be made of a material that varies in flexibility and/or rigidity based upon the temperature to which the sheath is exposed. In some embodiments, the sheath can be made of a material that has a reduced rigidity and/or increased flexibility upon exposure to heat, e.g., a temperature increase. In some embodiments, the sheath can be made of a urethane polycarbonate, or another form of urethane, or another plastic or non-plastic material that provides similar properties (such as a similar modulus of elasticity, modulus of rigidity (shear modulus), and/or bulk modulus). In such embodiments, during the insertion of the sheath into a patient, the sheath can absorb heat from the body of a patient or from other heat sources, and in response, reduce its rigidity. Such reduced rigidity can increase comfort to the patient, and/or reduce the likelihood of injury or tissue damage to the patient during the insertion and use of the sheath. In some embodiments, the sheath body 40 can be made of a material capable of withstanding the relative high pressures (e.g., 300 psi) and flow rates (e.g., 130 ml/min) associated with power injection.
Examples of bio-compatible materials that can be used for the sheath body 40, and that can include one or more of the properties described herein, such as flexibility, power injectable, and/or increased flexibility upon exposure to heat, are manufactured by AdvanSource Biomaterials Corp. (e.g., ChronoFlex C®) and Lubrizol (e.g., Carbothane TPU®). In some cases, even when the sheath material is selected to have certain properties, such as flexibility, the sheath can still kink when bent to a certain extent, for example, about 90 degrees. The method described herein can advantageously produce sheaths having improved flexibility, memory, kink-resistance and/or resilience.
In some embodiments, a sheath can be formed by extruding a selected material, for example, a polycarbonate-urethane copolymer as described herein, to form a medical article or tube and then annealing the extruded tube. Some polymers can be formed to include a mixture of crystalline regions and amorphous regions. Annealing can generally increase the crystallinity of a material and can involve heating the material to a temperature below its melting point, maintaining that temperature for a time period, and then cooling the material. The heat can provide energy to break existing bonds in the material so that atoms in the material can diffuse, redistribute, and form new bonds to create a more crystalline or organized structure. In some embodiments, an extruded tube can be annealed by heating the tube to a temperature of about 248° F. and maintaining the temperature for about one hour. Other durations and temperatures below the selected material's melting point are also possible.
Annealing can be used to change a material's structural or mechanical properties, such as strength and hardness. Annealing typically results in a more rigid material due to the increased crystallinity. However, when a polycarbonate-urethane copolymer extruded tube as described herein was annealed under certain conditions, the tube was found to have improved kink-resistance. For example, a tube extruded and annealed according to embodiments of the present disclosure was able to bend up to about 120 degrees before kinking. The process described herein can therefore be used to increase the flexibility of the tube. Alternatively or additionally, the process may provide the tube with greater kink or crease-resistance properties.
In one embodiment, a method of using a medical article having a flexible shaft made of annealed urethane polycarbonate includes inserting the shaft into a vessel over a guidewire, withdrawing the guidewire, and bending the shaft to lie substantially parallel to the skin, and retaining the shaft in the bent position without kinking the shaft. In such an embodiment, once the shaft is placed into a vessel, the shaft may be bent to lie across the skin so that it can be secured to the skin (e.g. with tape or another securement device) during use without kinking.
The extruded tube can be cut into desired lengths before or after annealing. The annealing process may alter the tube dimensions to some extent, for example, the tube may shrink slightly. Therefore, in some embodiments, if the extruded tube is cut before annealing, possible changes in dimension due to subsequent annealing are taken into account when cutting the tube. Additionally or alternatively, the tube can be rough cut before annealing and then trimmed to its desired length (e.g., 80 mm) afterward.
Methods for forming a more flexible or more kink-resistant tube as described herein can be used to form tubes for numerous applications. For example, the method can be used to form a sheath for a vascular access device as described herein. For this and other similar applications, the method can include additional steps to shape the tube for use. For example, the method can include flaring an end of the tube. This end is configured to be outside of the patient in use. The flare can then be over-molded onto a hub that will be part of the access device. The method can also or alternatively include forming an end of the tube into a tip. This end is configured to be inserted into the patient in use.
With reference to
With continued reference to
With further reference to
With continued reference to
As used herein, the terms “tube,” “tubular,” and the like are meant to be broad enough to refer to structures having at least one lumen, including structures that have (i) one or more lumens (e.g., multiple lumens); (ii) one or more lumens offset from a central longitudinal axis of the structure; (iii) a single lumen structure having a generally uniform wall thickness; and (iv) a single lumen that is coaxial with a central longitudinal of the structure. Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or states. Thus, such conditional language is not generally intended to imply that features, elements and/or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding whether these features, elements and/or states are included or are to be performed in any particular embodiment.
Although this disclosure has been described in the context of certain embodiments and examples, it will be understood by those skilled in the art that the disclosure extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses and obvious modifications and equivalents thereof. In addition, while several variations of the embodiments of the disclosure have been shown and described in detail, other modifications, which are within the scope of this disclosure, will be readily apparent to those of skill in the art. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the disclosure. It should be understood that various features and aspects of the disclosed embodiments can be combined with, or substituted for, one another in order to form varying modes of the embodiments of the disclosure. Thus, it is intended that the scope of the disclosure herein should not be limited by the particular embodiments described above.
Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57. This application is a National Phase Application of PCT International Application Number PCT/US2013/031040, filed Mar. 13, 2013, which claims the benefit of priority under 35 U.S.C. § 119(e) of U.S. Provisional Application No. 61/610,885 filed on Mar. 14, 2012, the entirety of each of which is incorporated herein by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/031040 | 3/13/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2013/138519 | 9/19/2013 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4155889 | Fagerburg et al. | May 1979 | A |
4963306 | Weldon | Oct 1990 | A |
5133336 | Savitt | Jul 1992 | A |
5199417 | Muller | Apr 1993 | A |
5229431 | Pinchuk | Jul 1993 | A |
5254662 | Szycher et al. | Oct 1993 | A |
5316706 | Muni | May 1994 | A |
5348538 | Wang et al. | Sep 1994 | A |
5735793 | Takahashi | Apr 1998 | A |
5741452 | Ryan | Apr 1998 | A |
5782811 | Samson et al. | Jun 1998 | A |
5895378 | Nita | Apr 1999 | A |
5938653 | Pepin | Aug 1999 | A |
5948345 | Patel et al. | Sep 1999 | A |
5951494 | Wang | Sep 1999 | A |
5971975 | Mills | Oct 1999 | A |
6129876 | Qin | Oct 2000 | A |
6197014 | Samson et al. | Mar 2001 | B1 |
6221097 | Wang | Apr 2001 | B1 |
6524299 | Tran | Feb 2003 | B1 |
6726659 | Stocking et al. | Apr 2004 | B1 |
7011872 | Ding | Mar 2006 | B2 |
7025746 | Tal | Apr 2006 | B2 |
7182755 | Tal | Feb 2007 | B2 |
D594981 | Bierman et al. | Jun 2009 | S |
D600793 | Bierman et al. | Sep 2009 | S |
D601242 | Bierman et al. | Sep 2009 | S |
D601243 | Bierman et al. | Sep 2009 | S |
D615201 | Bierman et al. | May 2010 | S |
7722567 | Tal | May 2010 | B2 |
D617893 | Bierman et al. | Jun 2010 | S |
D624643 | Bierman et al. | Sep 2010 | S |
D630729 | Bierman et al. | Jan 2011 | S |
7922696 | Tal et al. | Apr 2011 | B2 |
7931619 | Diamond et al. | Apr 2011 | B2 |
8105286 | Anderson et al. | Jan 2012 | B2 |
8192402 | Anderson et al. | Jun 2012 | B2 |
8202251 | Bierman et al. | Jun 2012 | B2 |
8377006 | Tal et al. | Feb 2013 | B2 |
8657790 | Tal et al. | Feb 2014 | B2 |
8672888 | Tal | Mar 2014 | B2 |
8747878 | Huang et al. | Jun 2014 | B2 |
8827958 | Bierman et al. | Sep 2014 | B2 |
8900192 | Anderson et al. | Dec 2014 | B2 |
8915884 | Tal et al. | Dec 2014 | B2 |
8956327 | Bierman et al. | Feb 2015 | B2 |
8974426 | Corcoran | Mar 2015 | B2 |
9138252 | Bierman et al. | Sep 2015 | B2 |
9566087 | Bierman et al. | Feb 2017 | B2 |
20010001113 | Lim et al. | May 2001 | A1 |
20020002363 | Urakawa | Jan 2002 | A1 |
20020072712 | Nool et al. | Jun 2002 | A1 |
20030006610 | Werth | Jan 2003 | A1 |
20030055402 | Zhou | Mar 2003 | A1 |
20040159968 | Lee | Aug 2004 | A1 |
20060096597 | Amann | May 2006 | A1 |
20060264904 | Kerby et al. | Nov 2006 | A1 |
20070167972 | Euteneuer et al. | Jul 2007 | A1 |
20070197855 | Richardson | Aug 2007 | A1 |
20080255417 | Bob | Oct 2008 | A1 |
20080262431 | Anderson | Oct 2008 | A1 |
20090179422 | Werth | Jul 2009 | A1 |
20090221961 | Tal et al. | Sep 2009 | A1 |
20090306327 | Stewart | Dec 2009 | A1 |
20100224276 | Forrester | Sep 2010 | A1 |
20100252965 | Wang et al. | Oct 2010 | A1 |
20110021994 | Anderson | Jan 2011 | A1 |
20110124772 | Wang | May 2011 | A1 |
20110202006 | Bierman et al. | Aug 2011 | A1 |
20110215505 | Kleiner et al. | Sep 2011 | A1 |
20110218496 | Bierman | Sep 2011 | A1 |
20110220270 | Koori | Sep 2011 | A1 |
20110276002 | Bierman | Nov 2011 | A1 |
20120041419 | Blanchard | Feb 2012 | A1 |
20120283640 | Bierman et al. | Nov 2012 | A1 |
20130092277 | Garrett | Apr 2013 | A1 |
20140025036 | Bierman et al. | Jan 2014 | A1 |
20140081210 | Bierman et al. | Mar 2014 | A1 |
20140207069 | Bierman et al. | Jul 2014 | A1 |
20150126930 | Bierman et al. | May 2015 | A1 |
20150190168 | Bierman et al. | Jul 2015 | A1 |
20150297868 | Tal et al. | Oct 2015 | A1 |
20150351793 | Bierman et al. | Dec 2015 | A1 |
20170035459 | Bierman et al. | Feb 2017 | A1 |
20170043100 | Nguyen et al. | Feb 2017 | A1 |
20180001060 | Bierman et al. | Jan 2018 | A1 |
Number | Date | Country |
---|---|---|
0 927 559 | Jul 1999 | EP |
1 344 549 | Sep 2003 | EP |
03-73167 | Mar 1991 | JP |
WO 199844979 | Oct 1998 | WO |
WO 9924084 | May 1999 | WO |
WO 04028611 | Apr 2004 | WO |
WO 2006122155 | Nov 2006 | WO |
WO 2007095040 | Aug 2007 | WO |
WO 2008131289 | Oct 2008 | WO |
WO 13138519 | Sep 2013 | WO |
Entry |
---|
Koenen, “Orthopedic Implant Materials of DSM Biomedical BV”, European Medical Polymers Conference 2010, Sep. 9, 2010, pp. 1-26 XP055211165, Belfast. |
Cipriani et al., “Thermoplastic Polyurethanes with Polycarbonate Soft Phase: Effect of Thermal Treatment on Phase Morphology”, Polymer Degradation and Stability. Sep. 1, 2012 pp. 1794-1800. XP05521128, DOI: 10.1016/j.polymdegradstab.2012.06.004 Retrieved from the Internet: URL:http://aperto.unit.it/retrieve/handle/2318/120601/17835/2012—Postprint-Zanetti cipriani—PDST—S-12-00524-OA 24m.pdf (retrieved on Sep. 4, 2015). |
Christenson et al., “Biodegradation Mechanisms of Polyurethane Elastomers”, Corrosion Engineering, Science and Technology, vol. 42, No. 4, Dec. 1, 2007 pp. 312-323, XP055211212, ISSN: 1478-422X, DOI: 10.1178/174327807X238909. |
“Processing guidelines ISOPLAST Engineering TPU resins,” Nov. 14, 2009 pp. 1-12, XP055211249, Retrieved from the internet: URL:http://webcache.googleusercontent.com/search?q=cache:hWysm_tpvs0J:https://www.lubrizol.com/Life-Science/Documents/Medical-Polymers/Processing-Guides/ISOPLAST-Processing-Guidlines.pdf+&cd=1 &hl=en&ct=clnk&gl=de (retrieved on Sep. 4, 2015). |
May 31, 2013 International Search Report and Written Opinion for Application No. PCT/US2013/031040 filed Mar. 13, 2013. |
U.S. Appl. No. 15/703,026, filed Sep. 13, 2017, Bierman et al. |
Supplementary European Search Report received in Application No. EP 13760352.8 dated Sep. 15, 2015. |
Examination Report received in Application No. EP 13760352.8 dated Dec. 1, 2016. |
International Preliminary Report on Patentability received in Application No. PCT/US2013/031040 dated Sep. 16, 2014. |
Examination Report received in in Application No. EP 13760352.8 dated Sep. 29, 2017. |
U.S. Appl. No. 15/887,170, filed Feb. 2, 2018, Bierman et al. |
Malinin, et al.: “Design of Medical Devices That Meet Contradictory Requirements,” The Open Medical Devices Journal, 2011, 3, 9-18. |
U.S. Appl. No. 29/375,448, filed Sep. 22, 2010, Bierman et al. |
U.S. Appl. No. 14/831,704, filed Oct. 20, 2015, Bierman et al. |
Number | Date | Country | |
---|---|---|---|
20150038944 A1 | Feb 2015 | US |
Number | Date | Country | |
---|---|---|---|
61610885 | Mar 2012 | US |